Biofrontera AG /
/
Ad hoc: Biofrontera AG - 500,000 shares subscribed in capital increase
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. Leverkusen, 3 February 2012 - Management and supervisory board of Biofrontera AG have decided to increase the company's base capital from EUR 11,240,486.00 by up to Euro 500,000.00 to up to EUR 11,740,486.00 through issuing 500,000 new ordinary shares from authorized capital II. The purchase right of the shareholders was excluded. According to today's tabulation, the private placement of the shares was successfully completed and over-subscribed. The registration of the shares will follow shortly. The proceeds of the capital increase amount to about € 1.5 mln. Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611 Contact:
Werner Pehlemann
Biofrontera AG
Tel.: +49 (0214) 87 63 20, Fax.: +49 (0214) 87 63 290
E-mail: w.pehlemann@biofrontera.com
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Biofrontera AG via Thomson Reuters ONE
HUG#1582430
|
